Table 4.
Cell viability assay. IC50 values of MP-HX and MP-EA on cancer and non-cancerous cell lines
| Treatment | HCT116 | HCC1937 | HepG2 | MDA-MB-231 | CCD841 | Hs27 |
|---|---|---|---|---|---|---|
| IC50 (μg/mL) | IC50 (μg/mL) | IC50 (μg/mL) | IC50 (μg/mL) | IC50 (μg/mL) | IC50 (μg/mL) | |
| MP-HX | 58.04 ± 0.96a | 94.80 ± 3.01a | 79.41 ± 1.88a | 57.81 ± 3.49a | 680.93 ± 8.76a | 311.30 ± 12.41a |
| MP-EA | 64.69 ± 0.72b | 95.71 ± 0.36a | 130.93 ± 3.17b | 97.09 ± 1.10b | 1218.33 ± 5.50b | 357.13 ± 5.11b |
| 5-FU | 13.81 ± 0.58c | 79.02 ± 2.12b | 95.02 ± 3.56c | 24.45 ± 4.52c | 9.64 ± 0.02c | > 250 |
Values are mean ± SD (n = 3). Mean values in each column with different letters (a, b and c) are significantly different (p < 0.05)